Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

0.8 ML Fondaparinux sodium 12.5 MG/ML Prefilled Syringe

Known as: FONDAPARINUX SODIUM 10 mg in 0.8 mL SUBCUTANEOUS INJECTION, SOLUTION [Fondaparinux Sodium], FONDAPARINUX NA 10MG/0.8ML INJ,SYRINGE,0.8ML [VA Product], FONDAPARINUX 10MG/0.8ML INJ SYR 0.8ML 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
BackgroundPharmacological thromboprophylaxis after colorectal cancer (CRC) surgery is internationally recommended for venous… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
2013
2013
Resumen La trombocitopenia inducida por heparina es una reaccion asociada al tratamiento con dicho farmaco. Se da hasta en el 3… Expand
2013
2013
Anti‐PF4/heparin antibodies are frequently generated after coronary artery bypass grafting (CABG) surgery, with platelet… Expand
2012
2012
Summary.  Background:  Thromboprophylaxis with rivaroxaban (R) is superior to enoxaparin in patients undergoing major orthopedic… Expand
2012
2012
PurposeFondaparinux, a selective activator factor X (factor Xa) inhibitor, is effective and safe for preventing venous… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
2010
2010
Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke - 
Review
2006
Review
2006
CONTEXT Fondaparinux, a factor Xa inhibitor, is approved for thromboprophylaxis after orthopedic surgery and for treatment of… Expand
  • table 1
  • table 3
  • table 4
  • table 5
  • table 6